ASPIRE CAPITAL PARTNERS LLC
Aspire Capital Fund LLC is a Chicago-based investment fund with a focus on making direct investments in publicly traded companies in a broad range of industries and investment structures. Aspire Capital Fund LLC is managed by Aspire Capital Partners LLC. They offer innovative investment structures designed for publicly traded companies whose prospects are bright, but who need additional capital to fuel their growth. Aspire Capital provides these companies with an easy and fair way to sell equity as the company achieves its business objectives.
ASPIRE CAPITAL PARTNERS LLC
Founded:
2009-01-01
Status:
Active
Contact:
(312) 658-0400
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Google Maps GStatic Google Static Content
Similar Organizations
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
Performant Capital
Performant Capital is an investment firm focused on majority and buyout investments in technology.
Current Employees Featured
Steven G. Martin Founder & Managing Member @ Aspire Capital Partners LLC
Founder & Managing Member
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-01 | Satsuma Pharmaceuticals | Aspire Capital Partners LLC investment in Post-IPO Equity - Satsuma Pharmaceuticals | 80 M USD |
| 2020-12-11 | Solid Biosciences | Aspire Capital Partners LLC investment in Post-IPO Equity - Solid Biosciences | 90 M USD |
| 2020-06-04 | Mereo Biopharma | Aspire Capital Partners LLC investment in Post-IPO Equity - Mereo Biopharma | 70 M USD |
| 2019-09-06 | Novan | Aspire Capital Partners LLC investment in Post-IPO Equity - Novan | 25 M USD |
| 2019-08-30 | Titan Medical | Aspire Capital Partners LLC investment in Post-IPO Equity - Titan Medical | 35 M USD |
| 2016-08-25 | Viking Therapeutics | Aspire Capital Partners LLC investment in Post-IPO Equity - Viking Therapeutics | 12.5 M USD |
| 2015-12-21 | Ritter Pharmaceuticals | Aspire Capital Partners LLC investment in Post-IPO Equity - Ritter Pharmaceuticals | 10 M USD |
| 2015-05-28 | Atossa Genetics | Aspire Capital Partners LLC investment in Post-IPO Equity - Atossa Genetics | 25 M USD |
| 2014-05-17 | Sophiris Bio | Aspire Capital Partners LLC investment in Post-IPO Equity - Sophiris Bio | 2 M USD |
| 2014-04-01 | Mobiquity Technologies | Aspire Capital Partners LLC investment in Post-IPO Equity - Mobiquity Technologies | 15 M USD |